P02 Category · further specificity required Newborn affected by complications of placenta, cord and membranes
ICD-10-CM P02 identifies “Newborn affected by complications of placenta, cord and membranes” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 16: Certain conditions originating in the perinatal period
Code-level instructions
Excludes 21
encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
Code first1
any current condition in newborn
Inherited instructions
Chapters 16 · Certain conditions originating in the perinatal period (P00-P96)
Includes1
conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
Excludes 25
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- tetanus neonatorum (A33)
Note1
Codes from this chapter are for use on newborn records only, never on maternal records
P00-P04 · Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery (P00-P04)
Note1
These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).
More specific codes
P02.0Newborn affected by placenta previaBillable / specificP02.1Newborn affected by other forms of placental separation and hemorrhageBillable / specificP02.2Newborn affected by other and unspecified morphological and functional abnormalities of placentaCategory · further specificity requiredP02.3Newborn affected by placental transfusion syndromesBillable / specificP02.4Newborn affected by prolapsed cordBillable / specificP02.5Newborn affected by other compression of umbilical cordBillable / specificP02.6Newborn affected by other and unspecified conditions of umbilical cordCategory · further specificity requiredP02.7Newborn affected by chorioamnionitisCategory · further specificity requiredP02.8Newborn affected by other abnormalities of membranesBillable / specificP02.9Newborn affected by abnormality of membranes, unspecifiedBillable / specificOfficial index references
References from other codes (1)
Inclusion terms · Newborn affected by conditions classifiable to O60-O75 and by procedures used in labor and delivery not included in P02.- and P03.0-P03.6
History
Code history
Latest recorded change · FY2017
Effective from
- Title changed
- Code-level rules changed
- Inherited rules changed
Newborn affected by complications of placenta, cord and membranes
Previous title: Newborn (suspected to be) affected by complications of placenta, cord and membranes
Category — select a more specific code
CDC/NCHS · FY2017All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | Title changed · Code-level rules changed · Inherited rules changed |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.